Published in Mol Cell Proteomics on October 03, 2011
Functional interaction of the ankylosing spondylitis-associated endoplasmic reticulum aminopeptidase 1 polymorphism and HLA-B27 in vivo. Mol Cell Proteomics (2012) 1.15
Translating DRiPs: MHC class I immunosurveillance of pathogens and tumors. J Leukoc Biol (2014) 0.97
The nature and extent of contributions by defective ribosome products to the HLA peptidome. Proc Natl Acad Sci U S A (2014) 0.92
The effect of proteasome inhibition on the generation of the human leukocyte antigen (HLA) peptidome. Mol Cell Proteomics (2013) 0.89
Peptide handling by HLA-B27 subtypes influences their biological behavior, association with ankylosing spondylitis and susceptibility to endoplasmic reticulum aminopeptidase 1 (ERAP1). Mol Cell Proteomics (2014) 0.84
Endoplasmic reticulum aminopeptidase 1 and rheumatic disease: functional variation. Curr Opin Rheumatol (2015) 0.80
Novel HLA-B27-restricted epitopes from Chlamydia trachomatis generated upon endogenous processing of bacterial proteins suggest a role of molecular mimicry in reactive arthritis. J Biol Chem (2013) 0.79
Proteasome inhibitors alter levels of intracellular peptides in HEK293T and SH-SY5Y cells. PLoS One (2014) 0.78
An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom (1994) 45.51
Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis (1999) 45.01
Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell (1978) 14.82
Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell (1994) 11.73
HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science (1992) 8.68
Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol (1994) 8.16
HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature (1992) 4.53
The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing. J Biol Chem (1997) 2.85
Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate. J Biol Chem (2006) 2.59
Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates. Methods Enzymol (2005) 2.49
Improving large-scale proteomics by clustering of mass spectrometry data. Proteomics (2004) 2.44
An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope. Nat Immunol (2003) 2.38
Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits. J Exp Med (1998) 2.32
The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J Immunol (1992) 2.27
Protein degradation and the generation of MHC class I-presented peptides. Adv Immunol (2002) 2.17
Microcolumns with self-assembled particle frits for proteomics. J Chromatogr A (2002) 2.17
Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. Immunity (2004) 2.13
Characterization of the proteasome using native gel electrophoresis. Methods Enzymol (2005) 1.89
The HLA-B*2705 peptidome. Arthritis Rheum (2010) 1.76
Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell (1996) 1.76
The structure and stability of an HLA-A*0201/octameric tax peptide complex with an empty conserved peptide-N-terminal binding site. J Immunol (2000) 1.74
Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1. Proc Natl Acad Sci U S A (1998) 1.72
Proteasome active sites allosterically regulate each other, suggesting a cyclical bite-chew mechanism for protein breakdown. Mol Cell (1999) 1.58
Contribution of proteasomal beta-subunits to the cleavage of peptide substrates analyzed with yeast mutants. J Biol Chem (1998) 1.57
The caspase-like sites of proteasomes, their substrate specificity, new inhibitors and substrates, and allosteric interactions with the trypsin-like sites. J Biol Chem (2003) 1.46
Toward a definition of self: proteomic evaluation of the class I peptide repertoire. J Immunol (2004) 1.33
Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes. Nat Immunol (2010) 1.24
Proteasome inhibition induces reversible impairments in protein synthesis. FASEB J (2006) 1.20
Two novel routes of transporter associated with antigen processing (TAP)-independent major histocompatibility complex class I antigen processing. J Exp Med (1997) 1.17
Critical role for the tapasin-docking site of TAP2 in the functional integrity of the MHC class I-peptide-loading complex. J Immunol (2005) 1.15
Isolation and characterization of a dibasic selective metalloendopeptidase from rat testes that cleaves at the amino terminus of arginine residues. J Biol Chem (1994) 1.13
Need for tripeptidyl-peptidase II in major histocompatibility complex class I viral antigen processing when proteasomes are detrimental. J Biol Chem (2006) 1.03
Production of an antigenic peptide by insulin-degrading enzyme. Nat Immunol (2010) 1.02
Differences in the expression of human class I MHC alleles and their associated peptides in the presence of proteasome inhibitors. J Immunol (2001) 1.02
Major histocompatibility complex class I viral antigen processing in the secretory pathway defined by the trans-Golgi network protease furin. J Exp Med (1998) 0.98
Proteasome inhibition by the natural products epoxomicin and dihydroeponemycin: insights into specificity and potency. Bioorg Med Chem Lett (1999) 0.96
Double-cleavage production of the CTL epitope by proteasomes and PA28: role of the flanking region. Genes Cells (1997) 0.95
The same natural ligand is involved in allorecognition of multiple HLA-B27 subtypes by a single T cell clone: role of peptide and the MHC molecule in alloreactivity. J Immunol (1998) 0.90
Re-evaluating the generation of a "proteasome-independent" MHC class I-restricted CD8 T cell epitope. J Immunol (2006) 0.90
Proteasome-independent HLA-B27 ligands arise mainly from small basic proteins. Mol Cell Proteomics (2007) 0.89
Limited diversity of peptides related to an alloreactive T cell epitope in the HLA-B27-bound peptide repertoire results from restrictions at multiple steps along the processing-loading pathway. J Immunol (2000) 0.89
Cytosolic aminopeptidases influence MHC class I-mediated antigen presentation in an allele-dependent manner. J Immunol (2009) 0.88
Allelic differences in the relationship between proteasome activity and MHC class I peptide loading. J Immunol (1998) 0.88
Studies on the subsite specificity of rat nardilysin (N-arginine dibasic convertase). J Biol Chem (2000) 0.87
Nardilysin cleaves peptides at monobasic sites. Biochemistry (2003) 0.87
Generation of MHC class I peptide antigens by protein processing in the secretory route by furin. Traffic (2000) 0.86
Endogenous processing and presentation of T-cell epitopes from Chlamydia trachomatis with relevance in HLA-B27-associated reactive arthritis. Mol Cell Proteomics (2009) 0.83
Protein Information and Knowledge Extractor: Discovering biological information from proteomics data. Proteomics (2010) 0.82
Role of furin in delivery of a CTL epitope of an anthrax toxin-fusion protein. Microbiol Immunol (2001) 0.81
Presentation of cytosolically stable peptides by HLA-B27 is not dependent on the canonic interactions of N-terminal basic residues in the A pocket. J Immunol (2009) 0.79
Improving large-scale proteomics by clustering of mass spectrometry data. Proteomics (2004) 2.44
The HLA-B*2705 peptidome. Arthritis Rheum (2010) 1.76
The turnover kinetics of major histocompatibility complex peptides of human cancer cells. Mol Cell Proteomics (2005) 1.33
The E2 ubiquitin-conjugating enzymes direct polyubiquitination to preferred lysines. J Biol Chem (2010) 1.28
The ubiquitin E3 ligase MARCH7 is differentially regulated by the deubiquitylating enzymes USP7 and USP9X. Traffic (2008) 1.22
Stable isotope labeling by amino acids in cell culture and differential plasma membrane proteome quantitation identify new substrates for the MARCH9 transmembrane E3 ligase. Mol Cell Proteomics (2009) 1.19
Soluble plasma HLA peptidome as a potential source for cancer biomarkers. Proc Natl Acad Sci U S A (2010) 1.18
Functional interaction of the ankylosing spondylitis-associated endoplasmic reticulum aminopeptidase 1 polymorphism and HLA-B27 in vivo. Mol Cell Proteomics (2012) 1.15
Molecular phenotype of zebrafish ovarian follicle by serial analysis of gene expression and proteomic profiling, and comparison with the transcriptomes of other animals. BMC Genomics (2006) 1.11
ERAP1 structure, function and pathogenetic role in ankylosing spondylitis and other MHC-associated diseases. Mol Immunol (2013) 1.02
Peptide rearrangement during quadrupole ion trap fragmentation: added complexity to MS/MS spectra. Anal Chem (2003) 0.98
Combined effects of ankylosing spondylitis-associated ERAP1 polymorphisms outside the catalytic and peptide-binding sites on the processing of natural HLA-B27 ligands. J Biol Chem (2013) 0.98
Analysis of endogenous peptides bound by soluble MHC class I molecules: a novel approach for identifying tumor-specific antigens. Eur J Immunol (2002) 0.94
The direction of protein entry into the proteasome determines the variety of products and depends on the force needed to unfold its two termini. Mol Cell (2012) 0.94
The peptide repertoires of HLA-B27 subtypes differentially associated to spondyloarthropathy (B*2704 and B*2706) differ by specific changes at three anchor positions. J Biol Chem (2002) 0.93
The nature and extent of contributions by defective ribosome products to the HLA peptidome. Proc Natl Acad Sci U S A (2014) 0.92
Tumor antigens and proteomics from the point of view of the major histocompatibility complex peptides. Mol Cell Proteomics (2003) 0.91
Comparative proteomics of the developing fish (zebrafish and gilthead seabream) oocytes. Comp Biochem Physiol Part D Genomics Proteomics (2007) 0.90
Proteasome-independent HLA-B27 ligands arise mainly from small basic proteins. Mol Cell Proteomics (2007) 0.89
The effect of proteasome inhibition on the generation of the human leukocyte antigen (HLA) peptidome. Mol Cell Proteomics (2013) 0.89
Multiple, non-conserved, internal viral ligands naturally presented by HLA-B27 in human respiratory syncytial virus-infected cells. Mol Cell Proteomics (2010) 0.88
Molecular mimicry of an HLA-B27-derived ligand of arthritis-linked subtypes with chlamydial proteins. J Biol Chem (2002) 0.88
Evaluation of prefractionation methods as a preparatory step for multidimensional based chromatography of serum proteins. Proteomics (2005) 0.88
Structural basis for T cell alloreactivity among three HLA-B14 and HLA-B27 antigens. J Biol Chem (2009) 0.88
Monoubiquitinylation regulates endosomal localization of Lst2, a negative regulator of EGF receptor signaling. Dev Cell (2009) 0.86
Insight into molecular pathways of retinal metabolism, associated with vitellogenesis in zebrafish. Am J Physiol Endocrinol Metab (2011) 0.85
Large-scale analysis of HLA peptides presented by HLA-Cw4. Immunogenetics (2003) 0.84
Multiple viral ligands naturally presented by different class I molecules in transporter antigen processing-deficient vaccinia virus-infected cells. J Virol (2011) 0.83
Novel technologies for cancer biomarker discovery: humoral proteomics. Cancer Biomark (2007) 0.83
Disparate folding and stability of the ankylosing spondylitis-associated HLA-B*1403 and B*2705 proteins. Arthritis Rheum (2008) 0.83
Natural HLA-B*2705 protein ligands with glutamine as anchor motif: implications for HLA-B27 association with spondyloarthropathy. J Biol Chem (2013) 0.82
Dominant role of the ERAP1 polymorphism R528K in shaping the HLA-B27 Peptidome through differential processing determined by multiple peptide residues. Arthritis Rheumatol (2015) 0.81
Two HLA-B14 subtypes (B*1402 and B*1403) differentially associated with ankylosing spondylitis differ substantially in peptide specificity but have limited peptide and T-cell epitope sharing with HLA-B27. J Biol Chem (2005) 0.81
Species-specific differences in proteasomal processing and tapasin-mediated loading influence peptide presentation by HLA-B27 in murine cells. J Biol Chem (2003) 0.81
Diversity of natural self-derived ligands presented by different HLA class I molecules in transporter antigen processing-deficient cells. PLoS One (2013) 0.80
Qualitative and quantitative differences in peptides bound to HLA-B27 in the presence of mouse versus human tapasin define a role for tapasin as a size-dependent peptide editor. J Immunol (2005) 0.80
Similar cell surface expression of beta2-microglobulin-free heavy chains by HLA-B27 subtypes differentially associated with ankylosing spondylitis. Arthritis Rheum (2005) 0.80
TAP-independent human histocompatibility complex-Cw1 antigen processing of an HIV envelope protein conserved peptide. AIDS (2011) 0.79
Presentation of cytosolically stable peptides by HLA-B27 is not dependent on the canonic interactions of N-terminal basic residues in the A pocket. J Immunol (2009) 0.79
Novel HLA-B27-restricted epitopes from Chlamydia trachomatis generated upon endogenous processing of bacterial proteins suggest a role of molecular mimicry in reactive arthritis. J Biol Chem (2013) 0.79
Nanofibers made of globular proteins. Biomacromolecules (2008) 0.79
Proteomics in clinical laboratory diagnosis. Adv Clin Chem (2005) 0.78
The effect of haptens on protein-carrier immunogenicity. Immunology (2015) 0.78
Allospecific T cell epitope sharing reveals extensive conservation of the antigenic features of peptide ligands among HLA-B27 subtypes differentially associated with spondyloarthritis. J Immunol (2003) 0.78
Comparative proteomics of small cell lung carcinoma. Cancer Biomark (2006) 0.78
Expression, purification and preliminary X-ray crystallographic analysis of the human major histocompatibility antigen HLA-B*1402 in complex with a viral peptide and with a self-peptide. Acta Crystallogr Sect F Struct Biol Cryst Commun (2007) 0.77
Proteomics profiling of human embryonic stem cells in the early differentiation stage. Stem Cell Rev (2012) 0.77
Mutational analysis reveals a complex interplay of peptide binding and multiple biological features of HLA-B27. J Biol Chem (2010) 0.77
Proteomics in cancer vaccine development. Expert Rev Proteomics (2005) 0.77
Recombinant human antibodies against the reverse transcriptase of human immunodeficiency virus type-1. Biochim Biophys Acta (2003) 0.76
The HLA-B27 peptidome: building on the cornerstone. Arthritis Rheum (2010) 0.76
MHC-bound antigens and proteomics for novel target discovery. Pharmacogenomics (2004) 0.76
ERAP1 in ankylosing spondylitis: genetics, biology and pathogenetic role. Curr Opin Rheumatol (2013) 0.76
A viral, transporter associated with antigen processing (TAP)-independent, high affinity ligand with alternative interactions endogenously presented by the nonclassical human leukocyte antigen E class I molecule. J Biol Chem (2012) 0.75
Centralized data analysis of a large interlaboratory proteomics project: a feasibility study. Proteomics (2005) 0.75
A novel DNA methyltransferase I-derived peptide eluted from soluble HLA-A*0201 induces peptide-specific, tumor-directed cytotoxic T cells. Int J Cancer (2004) 0.75